Biotech · Private company
Noema Pharma AG
Track this companyFree. Adds Noema Pharma AG to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BasimglurantPhase 3 · Trigeminal NeuralgiaClinicalTrials.gov · fetched Nov 12, 2026
- GemlapodectPhase 2 · Tourette SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NOE-105Phase 2 · Childhood-Onset Fluency DisorderClinicalTrials.gov · fetched Nov 12, 2026
- NOE-115Phase 2 · Menopause SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Pain Diary useTrigeminal NeuralgiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette SyndromePHASE2 · ACTIVE_NOT_RECRUITING · started Sep 10, 2024ClinicalTrials.gov NCT06315751 · fetched Nov 12, 2026
- A Study of NOE-115 in Women With Vasomotor Symptoms Due to MenopausePHASE2 · COMPLETED · started Apr 22, 2024ClinicalTrials.gov NCT06385795 · fetched Nov 12, 2026
- A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)PHASE2 · COMPLETED · started Jul 25, 2022ClinicalTrials.gov NCT05583955 · fetched Nov 12, 2026
- Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSCPHASE2 · COMPLETED · started Mar 3, 2022ClinicalTrials.gov NCT05059327 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 11, 2022ClinicalTrials.gov NCT05217628 · fetched Nov 12, 2026
- A Study to Validate a Pain Diary for Patient With Trigeminal NeuralgiaCOMPLETED · started Nov 20, 2021ClinicalTrials.gov NCT06019338 · fetched Nov 12, 2026